Detected ·
Oragen Therapeutics
——
Oragen Therapeutics is raising a funding round (115.9% funded with 155 investors) for their first-in-class oral RNA therapy targeting the $30B+ IBD market.
- Website
- oragen-therapeutics.com
- Amount
- —
- Stage
- —
- Event
- Funding round
- Detected
- 2026-04-14 09:06:28 UTC
- Signal ID
- f7fcbded-6832-4a22-b06d-ee0c28c698e4
As the API returns it
{
"id": "f7fcbded-6832-4a22-b06d-ee0c28c698e4",
"created_at": "2026-04-14T09:06:28.352680Z",
"company_name": "Oragen Therapeutics",
"company_website_url": "oragen-therapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/oragen-therapeutics",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": null,
"message": "*Oragen Therapeutics is raising a funding round (115.9% funded with 155 investors) for their first-in-class oral RNA therapy targeting the $30B+ IBD market.*"
}